Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Phone801-253-1600
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$882.75 million
Profitability
Miscellaneous
Employees5,783
Next Earnings DateN/A
OptionableOptionable
Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions
What is Merit Medical Systems' stock symbol?
Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."
How were Merit Medical Systems' earnings last quarter?
Merit Medical Systems, Inc. (NASDAQ:MMSI) issued its quarterly earnings results on Monday, February, 24th. The medical instruments supplier reported $0.40 EPS for the quarter, topping the consensus estimate of $0.34 by $0.06. The medical instruments supplier earned $257.92 million during the quarter, compared to analysts' expectations of $252.31 million. Merit Medical Systems had a net margin of 1.94% and a return on equity of 9.23%. Merit Medical Systems's revenue was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.48 EPS. View Merit Medical Systems' Earnings History.
What guidance has Merit Medical Systems issued on next quarter's earnings?
Merit Medical Systems issued an update on its FY20 earnings guidance on Monday, February, 24th. The company provided earnings per share guidance of $1.58-1.68 for the period, compared to the Thomson Reuters consensus estimate of $1.56. The company issued revenue guidance of $1.044-1.064 billion, compared to the consensus revenue estimate of $1.05 billion.
What price target have analysts set for MMSI?
9 brokerages have issued twelve-month price targets for Merit Medical Systems' stock. Their forecasts range from $26.00 to $74.00. On average, they expect Merit Medical Systems' share price to reach $40.33 in the next year. This suggests a possible upside of 4.1% from the stock's current price. View Analyst Price Targets for Merit Medical Systems.
What is the consensus analysts' recommendation for Merit Medical Systems?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 sell rating, 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Merit Medical Systems.
What are Wall Street analysts saying about Merit Medical Systems stock?
Here are some recent quotes from research analysts about Merit Medical Systems stock:
- 1. Barrington Research analysts commented, "We would gently suggest that with shares down over 55% over the past few months that perhaps the miss, the guidedown, the “drama”, and even a riskier near‐term growth profile might mostly be “in the stock” at this point. We simply think the risk/reward now favors investment – even if Q3 comes in soft. We will try to make our argument in brief below." (9/12/2019)
- 2. According to Zacks Investment Research, "Shares of Merit Medical outperformed the industry in a year’s time. Significant expansion in adjusted gross margins in recent times buoy optimism in the stock. Robust Cardiovascular unit also encourages. Management is optimistic about Merit Medical’s Becton Dickinson deal that is set for completion at the end of 2019. Cianna Medical and Vascular Insights buyouts continue to contribute to results. Management is optimistic about several new products that are slated for introduction in the second quarter of 2019. However, escalating operating expenses remains a concern for the company. Headwinds like stiff competition and higher consolidation in the healthcare industry add to the woes. Sluggishness in the Custom kits and procedure trays and Embolization devices units is also concern. The stock is overvalued at the moment." (7/1/2019)
- 3. Needham & Company LLC analysts commented, "MMSI’s 1Q19 revenue and EPS beat consensus (due to a lower than expected tax rate). Management reiterated its 2019 revenue and EPS guidance. Organic revenue growth slowed from 4Q18 despite an easier comp. Gross margin expansion was partially offset by higher SG&A but MMSI still delivered 60 bps of Y/Y operating margin improvement. We still believe there are multiple sources of upside to revenue (e.g. BD products are organic, Cianna SCOUT would be incremental) and EPS guidance (e.g. continued margin improvement) and we reiterate our Buy rating." (4/25/2019)
Has Merit Medical Systems been receiving favorable news coverage?
Press coverage about MMSI stock has trended neutral on Tuesday, according to InfoTrie. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Merit Medical Systems earned a coverage optimism score of 0.4 on InfoTrie's scale. They also gave media stories about the medical instruments supplier a news buzz of 9.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Merit Medical Systems.
Are investors shorting Merit Medical Systems?
Merit Medical Systems saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 6,990,000 shares, an increase of 16.9% from the January 15th total of 5,980,000 shares. Based on an average daily trading volume, of 978,600 shares, the days-to-cover ratio is presently 7.1 days. Approximately 13.1% of the shares of the company are sold short. View Merit Medical Systems' Current Options Chain.
Who are some of Merit Medical Systems' key competitors?
Some companies that are related to Merit Medical Systems include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), STAAR Surgical (STAA), Atrion (ATRI), Cerus (CERS), Anika Therapeutics (ANIK), Antares Pharma (ATRS), OraSure Technologies (OSUR) and Utah Medical Products (UTMD).
What other stocks do shareholders of Merit Medical Systems own?
Who are Merit Medical Systems' key executives?
Merit Medical Systems' management team includes the folowing people:
- Mr. Fred P. Lampropoulos, Chairman, CEO & Pres (Age 69)
- Mr. Ronald A. Frost, Chief Operating Officer (Age 57)
- Mr. Brian G. Lloyd, Chief Legal Officer & Corp. Sec. (Age 58)
- Mr. Joseph C. Wright, Pres of International Division (Age 49)
- Mr. Raul Parra Jr., CPA, CFO & Treasurer
Who are Merit Medical Systems' major shareholders?
Merit Medical Systems' stock is owned by a variety of of institutional and retail investors. Top institutional investors include ArrowMark Colorado Holdings LLC (9.57%), Nuance Investments LLC (3.82%), State Street Corp (3.55%), Conestoga Capital Advisors LLC (3.33%), Massachusetts Financial Services Co. MA (2.77%) and FMR LLC (2.02%). Company insiders that own Merit Medical Systems stock include Enterprise Associates 14 New, F Ann Millner, Franklin J Miller, Fred P Lampropoulos, Joseph Wright, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras, Raul Jr Parra and Ronald Frost. View Institutional Ownership Trends for Merit Medical Systems.
Which major investors are selling Merit Medical Systems stock?
MMSI stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Rothschild & Co. Asset Management US Inc., Public Employees Retirement Association of Colorado, UBS Asset Management Americas Inc., Conestoga Capital Advisors LLC, Credit Suisse AG, Bank of America Corp DE and Emerald Mutual Fund Advisers Trust. Company insiders that have sold Merit Medical Systems company stock in the last year include F Ann Millner, Franklin J Miller, Fred P Lampropoulos, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras and Raul Jr Parra. View Insider Buying and Selling for Merit Medical Systems.
Which major investors are buying Merit Medical Systems stock?
MMSI stock was acquired by a variety of institutional investors in the last quarter, including Nuance Investments LLC, ArrowMark Colorado Holdings LLC, William Blair Investment Management LLC, Massachusetts Financial Services Co. MA, Soltis Investment Advisors LLC, FMR LLC, Walthausen & Co. LLC and Peregrine Capital Management LLC. Company insiders that have bought Merit Medical Systems stock in the last two years include Enterprise Associates 14 New, Raul Jr Parra and Ronald Frost. View Insider Buying and Selling for Merit Medical Systems.
How do I buy shares of Merit Medical Systems?
Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Merit Medical Systems' stock price today?
One share of MMSI stock can currently be purchased for approximately $38.75.
How big of a company is Merit Medical Systems?
Merit Medical Systems has a market capitalization of $2.14 billion and generates $882.75 million in revenue each year. The medical instruments supplier earns $42.02 million in net income (profit) each year or $1.69 on an earnings per share basis. Merit Medical Systems employs 5,783 workers across the globe.View Additional Information About Merit Medical Systems.
What is Merit Medical Systems' official website?
How can I contact Merit Medical Systems?
Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at 801-253-1600 or via email at [email protected]
MarketBeat Community Rating for Merit Medical Systems (NASDAQ MMSI)
MarketBeat's community ratings are surveys of what our community members think about Merit Medical Systems and other stocks. Vote "Outperform" if you believe MMSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
